115TH CONGRESS 
2D SESSION 
H. R. 5353 
AN ACT 
To amend the Public Health Service Act to reauthorize and 
expand a program of surveillance and education, carried 
out by the Centers for Disease Control and Prevention, 
regarding infections associated with injection drug use. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Eliminating Opioid Re-
lated Infectious Diseases Act of 2018’’. 
SEC. 2. REAUTHORIZATION AND EXPANSION OF PROGRAM 
OF 
SURVEILLANCE 
AND 
EDUCATION 
RE-
GARDING INFECTIONS ASSOCIATED WITH IL-
LICIT DRUG USE AND OTHER RISK FACTORS. 
Section 317N of the Public Health Service Act (42 
U.S.C. 247b–15) is amended to read as follows: 
‘‘SEC. 317N. SURVEILLANCE AND EDUCATION REGARDING 
INFECTIONS 
ASSOCIATED 
WITH 
ILLICIT 
DRUG USE AND OTHER RISK FACTORS. 
‘‘(a) IN GENERAL.—The Secretary may (directly and 
through grants to public and nonprofit private entities) 
provide for programs for the following: 
‘‘(1) To cooperate with the States and Indian 
tribes in implementing or maintaining a surveillance 
system to determine the incidence of infections com-
monly associated with illicit drug use, including in-
fections commonly associated with injection drug use 
such as viral hepatitis, human immunodeficiency 
virus, and infective endocarditis, and to assist the 
States in determining the prevalence of such infec-
tions, which may include the reporting of cases of 
such infections.
‘‘(2) To identify, counsel, and offer testing to 
individuals who are at risk of infections as a result 
of injection drug use, receiving blood transfusions 
prior to July 1992, or other risk factors. 
‘‘(3) To provide appropriate referrals for coun-
seling, testing, and medical treatment of individuals 
identified under paragraph (2) and to ensure, to the 
extent practicable, the provision of appropriate fol-
low-up services. 
‘‘(4) To develop and disseminate public infor-
mation and education programs for the detection 
and control of infections described in paragraph (1), 
with priority given to high-risk populations as deter-
mined by the Secretary. 
‘‘(5) To improve the education, training, and 
skills of health professionals in the detection and 
control of infections and the coordination of treat-
ment of addiction and infectious diseases described 
in paragraph (1), with priority given to substance 
use disorder treatment providers, pediatricians and 
other primary care providers, obstetrician-gyne-
cologists, infectious diseases clinicians, and HIV cli-
nicians. 
‘‘(b) LABORATORY
PROCEDURES.—The Secretary 
may (directly or through grants to public and nonprofit
private entities) carry out programs to provide for im-
provements in the quality of clinical-laboratory procedures 
regarding infections described in subsection (a)(1). 
‘‘(c) DEFINITIONS.—In this section: 
‘‘(1) The term ‘Indian tribe’ has the meaning 
given that term in section 4 of the Indian Self-De-
termination and Education Assistance Act. 
‘‘(2) The term ‘injection drug use’ means— 
‘‘(A) intravenous administration of a sub-
stance in schedule I under section 202 of the 
Controlled Substances Act; 
‘‘(B) intravenous administration of a sub-
stance in schedule II, III, IV, or V under sec-
tion 202 of the Controlled Substances Act that 
has not been approved for intravenous use 
under— 
‘‘(i) section 505 of the Federal Food, 
Drug and Cosmetic Act; or 
‘‘(ii) section 351 of the Public Health 
Service Act; or 
‘‘(C) intravenous administration of a sub-
stance in schedule II, III, IV, or V under sec-
tion 202 of the Controlled Substances Act that 
has not been prescribed to the person using the 
substance.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated $40,000,000 for each of the fiscal years 
2019 through 2023.’’. 
Passed the House of Representatives June 12, 2018. 
Attest: 
Clerk.
115TH CONGRESS 
2D SESSION 
H. R. 5353 
AN ACT 
To amend the Public Health Service Act to reau-
thorize and expand a program of surveillance and 
education, carried out by the Centers for Disease 
Control and Prevention, regarding infections as-
sociated with injection drug use.